Patents by Inventor Haruko Yamabe

Haruko Yamabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dihydropseudoerythromycin derivatives
    Patent number: 8133871
    Abstract: A compound represented by the formula [I] wherein each symbol is as defined in the specification or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound as an active ingredient.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: March 13, 2012
    Assignees: The Kitasato Institute, Aphoenix, Inc.
    Inventors: Satoshi Omura, Toshiaki Sunazuka, Kenichiro Nagai, Hideaki Shima, Haruko Yamabe
  • Novel Dihydropseudoerythromycin Derivatives
    Publication number: 20090131341
    Abstract: A compound represented by the formula [I] wherein each symbol is as defined in the specification or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound as an active ingredient.
    Type: Application
    Filed: October 13, 2006
    Publication date: May 21, 2009
    Inventors: Satoshi Omura, Toshiaki Sunazuka, Kenichiro Nagai, Hideaki Shima, Haruko Yamabe
  • Cyclic amide derivatives
    Patent number: 7166617
    Abstract: Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1 and R2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: wherein R3, R4, R5, and R6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: represents an aromatic heterocyclic ring.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: January 23, 2007
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Haruko Yamabe, Masahiro Okuyama, Akira Nakao, Mitsuru Ooizumi, Ken-ichi Saito
  • Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide
    Patent number: 6884805
    Abstract: The invention relates to novel polymorph crystal forms A and B of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide: The compounds and pharmaceutical compositions thereof are useful for activating a malfunctioned cholinergic neuron that is associated with memory loss disturbances.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: April 26, 2005
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Haruko Yamabe, Takayuki Ishige
  • Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide
    Publication number: 20040122034
    Abstract: The invention relates to novel polymorph crystal forms A and B of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide: 1
    Type: Application
    Filed: October 17, 2003
    Publication date: June 24, 2004
    Inventors: Haruko Yamabe, Takayuki Ishige
  • Novel cyclic amide derivatives
    Publication number: 20030212094
    Abstract: Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: 1
    Type: Application
    Filed: December 30, 2002
    Publication date: November 13, 2003
    Inventors: Haruko Yamabe, Masahiro Okuyama, Akira Nakao, Mitsuru Ooizumi, Ken-ichi Saito